1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Immunoglobulin Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Immunoglobulin Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Intramuscular Injection
1.4.3 Intravenous Injection
1.5 Market by Application
1.5.1 Global Human Immunoglobulin Market Share by Application: 2021-2026
1.5.2 Disease Prevention
1.5.3 Treatment
1.5.4 Diagnosis
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Human Immunoglobulin Market
1.8.1 Global Human Immunoglobulin Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Human Immunoglobulin Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Human Immunoglobulin Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Human Immunoglobulin Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Human Immunoglobulin Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Human Immunoglobulin Sales Volume Market Share by Region (2015-2020)
3.2 Global Human Immunoglobulin Sales Revenue Market Share by Region (2015-2020)
3.3 North America Human Immunoglobulin Sales Volume
3.3.1 North America Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.3.2 North America Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Human Immunoglobulin Sales Volume
3.4.1 East Asia Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Human Immunoglobulin Sales Volume (2015-2020)
3.5.1 Europe Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Human Immunoglobulin Sales Volume (2015-2020)
3.6.1 South Asia Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Human Immunoglobulin Sales Volume (2015-2020)
3.7.1 Southeast Asia Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Human Immunoglobulin Sales Volume (2015-2020)
3.8.1 Middle East Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Human Immunoglobulin Sales Volume (2015-2020)
3.9.1 Africa Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Human Immunoglobulin Sales Volume (2015-2020)
3.10.1 Oceania Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Human Immunoglobulin Sales Volume (2015-2020)
3.11.1 South America Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.11.2 South America Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Human Immunoglobulin Sales Volume (2015-2020)
3.12.1 Rest of the World Human Immunoglobulin Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Human Immunoglobulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Human Immunoglobulin Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Human Immunoglobulin Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Human Immunoglobulin Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Human Immunoglobulin Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Human Immunoglobulin Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Human Immunoglobulin Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Human Immunoglobulin Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Human Immunoglobulin Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Human Immunoglobulin Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Human Immunoglobulin Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Human Immunoglobulin Sales Volume Market Share by Type (2015-2020)
14.2 Global Human Immunoglobulin Sales Revenue Market Share by Type (2015-2020)
14.3 Global Human Immunoglobulin Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Human Immunoglobulin Consumption Volume by Application (2015-2020)
15.2 Global Human Immunoglobulin Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Human Immunoglobulin Business
16.1 Takeda
16.1.1 Takeda Company Profile
16.1.2 Takeda Human Immunoglobulin Product Specification
16.1.3 Takeda Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Hualan Bio
16.2.1 Hualan Bio Company Profile
16.2.2 Hualan Bio Human Immunoglobulin Product Specification
16.2.3 Hualan Bio Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Octapharma
16.3.1 Octapharma Company Profile
16.3.2 Octapharma Human Immunoglobulin Product Specification
16.3.3 Octapharma Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 CSL
16.4.1 CSL Company Profile
16.4.2 CSL Human Immunoglobulin Product Specification
16.4.3 CSL Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 CTBB
16.5.1 CTBB Company Profile
16.5.2 CTBB Human Immunoglobulin Product Specification
16.5.3 CTBB Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Grifols
16.6.1 Grifols Company Profile
16.6.2 Grifols Human Immunoglobulin Product Specification
16.6.3 Grifols Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Shanxi Kangbao Biological Product
16.7.1 Shanxi Kangbao Biological Product Company Profile
16.7.2 Shanxi Kangbao Biological Product Human Immunoglobulin Product Specification
16.7.3 Shanxi Kangbao Biological Product Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 China National Pharmaceutical Group Corporation
16.8.1 China National Pharmaceutical Group Corporation Company Profile
16.8.2 China National Pharmaceutical Group Corporation Human Immunoglobulin Product Specification
16.8.3 China National Pharmaceutical Group Corporation Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Biotest
16.9.1 Biotest Company Profile
16.9.2 Biotest Human Immunoglobulin Product Specification
16.9.3 Biotest Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 RASS
16.10.1 RASS Company Profile
16.10.2 RASS Human Immunoglobulin Product Specification
16.10.3 RASS Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Shuanglin Bio Pharma
16.11.1 Shuanglin Bio Pharma Company Profile
16.11.2 Shuanglin Bio Pharma Human Immunoglobulin Product Specification
16.11.3 Shuanglin Bio Pharma Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Sichuan Yuanda Shuyang Pharmaceutical
16.12.1 Sichuan Yuanda Shuyang Pharmaceutical Company Profile
16.12.2 Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Product Specification
16.12.3 Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Human Immunoglobulin Manufacturing Cost Analysis
17.1 Human Immunoglobulin Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Human Immunoglobulin
17.4 Human Immunoglobulin Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Human Immunoglobulin Distributors List
18.3 Human Immunoglobulin Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Human Immunoglobulin (2021-2026)
20.2 Global Forecasted Revenue of Human Immunoglobulin (2021-2026)
20.3 Global Forecasted Price of Human Immunoglobulin (2015-2026)
20.4 Global Forecasted Production of Human Immunoglobulin by Region (2021-2026)
20.4.1 North America Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.3 Europe Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.7 Africa Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.9 South America Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Human Immunoglobulin Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Human Immunoglobulin by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Human Immunoglobulin by Country
21.2 East Asia Market Forecasted Consumption of Human Immunoglobulin by Country
21.3 Europe Market Forecasted Consumption of Human Immunoglobulin by Countriy
21.4 South Asia Forecasted Consumption of Human Immunoglobulin by Country
21.5 Southeast Asia Forecasted Consumption of Human Immunoglobulin by Country
21.6 Middle East Forecasted Consumption of Human Immunoglobulin by Country
21.7 Africa Forecasted Consumption of Human Immunoglobulin by Country
21.8 Oceania Forecasted Consumption of Human Immunoglobulin by Country
21.9 South America Forecasted Consumption of Human Immunoglobulin by Country
21.10 Rest of the world Forecasted Consumption of Human Immunoglobulin by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer